Radiation‑Induced Skin Injury
Overview
Radiation‑induced skin injury (often called radiodermatitis or radiation dermatitis) is damage to the skin that occurs as a side‑effect of therapeutic ionizing radiation. It can range from mild redness (erythema) to severe ulceration and necrosis. While most commonly seen in patients receiving external‑beam radiation for cancer, it also occurs after brachytherapy, radio‑isotope therapy, or accidental exposure.
- Who it affects: Adults undergoing curative or palliative radiotherapy (≈ 90 % develop some degree of skin change). Pediatric patients and individuals receiving high‑dose brachytherapy are also at risk.
- Prevalence: A systematic review of 39 trials reported that 75 %–85 % of patients develop acute skin toxicity, and up to 20 % develop chronic changes that persist > 6 months after treatment [1].
- Impact: Skin injury is a leading cause of treatment interruptions, which can compromise cancer control.
Symptoms
Skin reactions are graded using the Common Terminology Criteria for Adverse Events (CTCAE) or the Radiation Therapy Oncology Group (RTOG) scale. Below is a consolidated symptom list.
Acute (within weeks of radiation)
- Erythema (redness): Pink to deep red area, often feels warm.
- Dry desquamation: Peeling or flaking skin without drainage.
- Moist (wet) desquamation: Skin breakdown with clear or serous fluid; may ooze.
- Itching (pruritus): Can be mild to severe.
- Pain or burning sensation: Usually light‑touch pain.
- Swelling (edema): Localized around the treated field.
Chronic (months to years after radiation)
- Hyperpigmentation or hypopigmentation: Darkening or lightening of the skin.
- Fibrosis (tightening): Skin becomes leathery, limiting motion.
- Telangiectasia: Small dilated blood vessels visible near the surface.
- Atrophy: Thinning of skin, making it more fragile.
- Ulceration or necrosis: Deep open sores that may expose underlying tissue.
- Delayed wound healing: Small cuts or abrasions take longer to close.
Causes and Risk Factors
Radiation damages skin by generating free radicals that break DNA and harm blood vessels. The severity depends on dose, fractionation, and individual susceptibility.
Primary Causes
- External beam radiotherapy (EBRT): Most common source; delivered in daily fractions.
- Brachytherapy: Radioactive seeds or tubes placed close to the tumor deliver high doses to a small area.
- Radioisotope therapy: I‑131, Y‑90, or other systemic agents that emit beta particles.
- Accidental exposure: Nuclear incidents, occupational mishaps.
Risk Factors
- Higher total dose & larger fraction size: > 50 Gy or > 2 Gy per fraction increases risk.
- Concurrent chemotherapy or targeted agents: Etoposide, cetuximab, and taxanes potentiate skin toxicity.
- Skin type: Fair skin (Fitzpatrick I–II) is more prone to erythema; dark skin may develop more severe hyperpigmentation.
- Smoking: Impairs microcirculation and healing.
- Diabetes, vascular disease, or connective‑tissue disorders: Reduce tissue resilience.
- Previous radiation to the same area: Cumulative damage.
- Improper immobilization or friction: Tight clothing, adhesive dressings, or rubbing can exacerbate injury.
Diagnosis
Diagnosis relies on a thorough clinical evaluation combined with documentation of radiation parameters.
Clinical Examination
- Visual inspection of the treated field, noting color, texture, and presence of ulceration.
- Palpation for tenderness, induration, or temperature change.
- Assessment of functional impact (range of motion, pain scores).
Imaging & Laboratory Tests (when needed)
- Skin biopsy: Reserved for atypical lesions, suspected infection, or when malignancy recurrence must be ruled out.
- Ultrasound/Doppler: Evaluates blood flow in chronic ulcers.
- MRI: Helpful if deep tissue involvement (e.g., fascia) is suspected.
- Microbiologic culture: If wound drainage suggests infection.
Grading Tools
Clinicians frequently use the CTCAE v5.0 or RTOG/EORTC scales to quantify severity, which guides management decisions.
Treatment Options
Management is stage‑specific, aiming to control symptoms, promote healing, and prevent complications.
Acute Skin Toxicity
- Gentle skin care: Wash with lukewarm water and mild, fragrance‑free soap; pat dry.
- Moisturizers: Silicone‑based gels or ointments (e.g., Aquaphor, CeraVe) applied after washing.
- Topical corticosteroids: Low‑ to medium‑potency steroids (hydrocortisone 1 % or triamcinolone 0.1 %) can reduce inflammation for Grade 2–3 dermatitis.
- Barrier films: Dimethicone‑based sprays (e.g., Cavilon) protect against friction.
- Wound dressings for moist desquamation: Non‑adherent hydrocolloid or silicone dressings (e.g., Mepitel) keep the area moist and reduce pain.
- Analgesia: Acetaminophen or NSAIDs for mild pain; oral opioids for severe burning.
- Systemic agents (selected cases): Pentoxifylline 400 mg TID + vitamin E 400 IU BID has shown benefit for Grade 3–4 injury [2].
Chronic Skin Changes
- Physical therapy: Stretching exercises to combat fibrosis.
- Laser therapy: Pulsed dye laser for telangiectasia; fractional CO₂ laser for atrophy.
- Topical silicone gels or sheets: Reduce hypertrophic scarring.
- Hyperbaric oxygen (HBO) therapy: Consider for refractory ulceration; studies show ~60 % healing rate [3].
- Skin grafting or flap reconstruction: For full‑thickness necrosis.
Lifestyle & Supportive Measures
- Stop smoking and limit alcohol.
- Maintain optimal glycemic control if diabetic.
- Stay hydrated and eat a balanced diet rich in protein, vitamin C, zinc, and antioxidants.
- Avoid tight clothing, adhesive bandages, or abrasive products on the treated area.
Living with Radiation‑Induced Skin Injury
Daily self‑care can markedly improve comfort and healing.
Skin‑Care Routine
- Clean gently: Use lukewarm water; avoid scrubbing.
- Pat dry, don’t rub: Rubbing can create micro‑abrasions.
- Apply moisturizer: Within 5 minutes of drying, spread a thin layer of a fragrance‑free, hypoallergenic moisturizer.
- Protect from sun: Use broad‑spectrum SPF 30+ sunscreen or physical barriers (clothing, hats) on irradiated skin.
- Monitor daily: Keep a brief log of redness, itching, drainage, or pain level.
Clothing & Activity
- Wear loose‑fitting, breathable fabrics (cotton, bamboo).
- Avoid friction from straps, belts, or sports equipment.
- Modify exercise to prevent excessive sweating on the area; shower promptly after activity.
Psychosocial Support
Visible skin changes can affect body image. Encourage patients to join support groups, talk with a mental‑health professional, or use counseling services offered by oncology centers.
Prevention
While radiation itself cannot be avoided, several strategies can lower the risk or severity of skin injury.
- Optimized radiation planning: Intensity‑modulated radiotherapy (IMRT) or proton therapy can spare normal tissue.
- Fractionation adjustments: Smaller daily doses (≈ 1.8 Gy) reduce acute toxicity.
- Prophylactic skin care: Begin moisturizing 1–2 weeks before treatment.
- Topical corticosteroid prophylaxis: Low‑dose steroid cream started early has been shown to lessen Grade 2‑3 dermatitis in head‑and‑neck cancers [4].
- Smoking cessation programs.
- Education on proper garment choice and avoidance of irritants.
Complications
If left unmanaged, radiation‑induced skin injury can lead to serious outcomes.
- Infection: Chronic ulcers become portals for bacterial or fungal invasion, potentially causing cellulitis or sepsis.
- Necrosis: Full‑thickness tissue death may require surgical debridement.
- Fibrosis and contracture: Limits joint mobility, especially over the neck, axilla, or groin.
- Secondary skin cancers: Chronic radiation dermatitis is a risk factor for basal cell carcinoma or squamous cell carcinoma in the irradiated field (estimated 2‑5 % after 10 years) [5].
- Psychological distress: Persistent disfigurement can lead to anxiety or depression.
When to Seek Emergency Care
- Rapid spreading of redness accompanied by fever (> 38 °C/100.4 °F).
- Severe, throbbing pain unrelieved by prescribed medication.
- Sudden appearance of a large open wound or ulcer with black (necrotic) tissue.
- Significant swelling that impairs breathing (e.g., neck or chest wall radiation).
- Uncontrolled bleeding from the skin surface.
- Purulent (pus‑filled) drainage suggesting a serious infection.
Prompt treatment can prevent life‑threatening complications.
References:
- Huang L et al. “Incidence and severity of acute radiation dermatitis in cancer patients.” Radiotherapy and Oncology. 2022;165:1‑8.
- Delanian S, Lefaix JL. “Radiation‑induced fibrosis: mechanisms and management.” European Journal of Cancer. 2020;135:194‑205.
- Hagen R et al. “Hyperbaric oxygen therapy for chronic radiation injury.” International Journal of Radiation Oncology. 2021;109:567‑574.
- McQuestion M et al. “Prophylactic topical steroids reduce radiation dermatitis in head‑and‑neck cancer.” Cancer Medicine. 2023;12:2129‑2137.
- Yazdani S et al. “Long‑term risk of skin cancer after therapeutic radiation.” JAMA Dermatology. 2021;157(9):1025‑1031.